SciSparc Ltd. SPRC 深 沪
已收盘 02-06 16:00:00 美东时间
0.684
+0.072
+11.75%
华盛通- 最 高0.684
- 今 开0.627
- 成交量 10.04万股
- 最 低 0.6109
- 昨 收 0.6121
- 总市值 297.57万
- 52周最高 10.92
- 市盈率 静 --
- 换手率 2.31%
- 52周最低 0.5838
- 委 比 -20.63%
- 总股本 435.05万
- 历史最高 3865.68
- 量 比 0.34
- 振 幅 11.94%
- 历史最低 0.5838
- 每 手 1
- 风险率 2.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SciSparc Shareholders Approve February Governance Agenda
SciSparc Ltd. ( ($SPRC) ) has shared an update. Shareholders approved all propo...
02-05 05:30
CORRECTION: SciSparc Acquires MUSE IP Portfolio From Xylo in Equity-Based Asset Deal; SciSparc Issued To Xylo An Amount Of Ordinary Shares Of The Company, Which Represents 19.99% Of The Issued And Outstanding Share Capital Of SciSparc
SciSparc intends to target the global multi- billion dollar GERD device marketTEL AVIV, Israel, Jan. 26, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a company engaged in clinical-stage
01-26 21:19
SciSparc Acquires IP Portfolio Of Patents, Trademarks, IP Rights For Endoscopic Systems, Medical Cameras; Financial Terms Not Disclosed
SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a company engaged in clinical-stage pharmaceutical developments through its majority-owned subsidiary NeuroThera Labs Inc., announced today the closing of the
01-26 21:17
SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization
<p>SciSparc announced the acquisition of intellectual property from Xylo Technologies, including the MUSE™ system, designed for treating GERD. Targeting the global GERD device market valued at $2.5 billion in 2024, SciSparc plans to replicate Xylo's successful licensing model in high-growth regions to accelerate commercialization and revenue.</p>
01-26 13:13
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Greenwich LifeSciences (NASDAQ:GLSI) shares rose 48.6% to $33.13 durin...
01-22 20:05
SciSparc Moves Into Endoscopy With Strategic Patent Deal
SciSparc shares fall after the company agrees to acquire endoscopy-related patents as it pushes into medical devices.
01-14 02:39
Market-Moving News for January 13th
LHX: 13% | L3Harris Technologies shares are trading higher after the company announced plans to create an independently traded missile solutions business with a $1 billion convertible preferred investment from the
01-13 20:18
SciSparc to Acquire MUSE GERD Device IP in Deal Valued at 19.99% Equity Stake
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a company engaged in clinical-stage pharmaceutical developments through its majority-owned subsidiary NeuroThera Labs Inc., announced today the signing of a
01-13 19:58
SciSparc Receives Nasdaq Notice Over Minimum Stockholders’ Equity Non-Compliance
SciSparc Ltd. ( ($SPRC) ) has provided an announcement. On January 12, 2026, Sc...
01-13 05:28
SciSparc Receives Nasdaq Notification Letter
SciSparc Ltd. (NASDAQ:SPRC) ("Company" or "SciSparc"), a company engaged in clinical-stage pharmaceutical developments through its majority-owned subsidiary NeuroThera Labs Inc., announced today that it has received a
01-13 05:05
